Multimodal Prehabilitation To Improve The Clinical Outcomes Of Frail Elderly Patients With Gastric Cancer

NCT05352802 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 368

Last updated 2024-12-13

No results posted yet for this study

Summary

The GISSG+2201 study was launched by Shandong Gastrointestinal Surgery Study Group (GISSG). The intention is to establish a multimodal prehabilitation protocol in frail elderly patients who undergo gastric cancer radical surgery, explore the feasibility and effectiveness of the measures and evaluate the effect of program on short-term clinical outcome, recovery index and the long-term tumor-related outcome.

Conditions

  • Stomach Neoplasms
  • Frail Elderly

Interventions

BEHAVIORAL

Multimodal prehabilitation program

Multimodal prehabilitation programs have adopted planned, structural, repetitive and purposeful approach that includes elements of exercise, nutritional and psychological.

BEHAVIORAL

ERAS protocol

The core content is to adopt a series of optimized measures performed during the perioperative period on the basis of evidence-based medical findings to reduce the physiological and psychological stress of patients and to accelerate their recovery.

Sponsors & Collaborators

  • Shandong Provincial Hospital

    collaborator OTHER_GOV
  • Qilu Hospital of Shandong University

    collaborator OTHER
  • Qianfoshan Hospital

    collaborator OTHER
  • Yantai Yuhuangding Hospital

    collaborator OTHER
  • Jining First People's Hospital

    collaborator OTHER
  • Weifang Medical University

    collaborator OTHER
  • Weifang People's Hospital

    collaborator OTHER
  • Dongying People's Hospital

    collaborator OTHER
  • Weihai Municipal Hospital

    collaborator OTHER
  • Weihai Central Hospital

    collaborator OTHER
  • Rizhao People's Hospital

    collaborator OTHER
  • Liaocheng People's Hospital

    collaborator OTHER
  • The Affiliated Hospital of Qingdao University

    lead OTHER

Principal Investigators

  • Yanbing Zhou, MD · The Affiliated Hospital of Qingdao University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2024-04-13
Completion
2027-05-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05352802 on ClinicalTrials.gov